BCL2A1 and diffuse large B-cell lymphoma: In particular DLBCL displays a high but very heterogeneous expression of the anti-apoptotic protein BCL2A1, indicating a potential role of BCL2A1 in tumourigenesis and giving rise to our hypothesis that BCL2A1 may be a promising therapeutic target.